The cardiovascular system medicine sales in Austria were valued at 375 million euros in 2023. Forecasted data indicates a steady decline from 370.7 million euros in 2024 to 356.2 million euros by 2028. This trend shows a consistent year-on-year decrease, with an average annual percentage decline over the last five years (CAGR) being approximately 1.07%.

Trends to watch for include:

Potential impact of emerging generic alternatives on market values.
Influence of healthcare policy changes regarding cardiovascular treatments.
Advancements in treatment technologies and their adoption rates.
Changes in demographic trends such as aging population and its impact on demand.